| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5682746 | La Presse Médicale | 2017 | 5 Pages |
Abstract
Randomized trials in “all coming” patients are already on their way, and the future of TAVI is to be the reference treatment for a vast majority of patients with aortic stenosis.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Anastasia Sokoloff, Hélène Eltchaninoff,